BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33191144)

  • 1. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors.
    Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J
    Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of spectral CT combined with perfusion scan in diagnosis of pancreatic neuroendocrine tumors.
    Wan Y; Hao H; Chen Y; Zhang Y; Yue Q; Li Z
    Insights Imaging; 2022 Sep; 13(1):145. PubMed ID: 36057734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
    Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
    Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
    Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
    Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
    Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
    Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
    Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
    Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of CT Perfusion Parameters of Focal Pancreatic Lesions and Data Comparison of Different Algorithms.
    Li P; Zhu L; Xue H; Liu C; Xu K; Li J; Sun T; Jin Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):80-87. PubMed ID: 28270288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
    Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
    Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
    Canellas R; Burk KS; Parakh A; Sahani DV
    AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT texture analysis of liver metastases in PNETs versus NPNETs: Correlation with histopathological findings.
    Martini I; Polici M; Zerunian M; Panzuto F; Rinzivillo M; Landolfi F; Magi L; Caruso D; Eid M; Annibale B; Laghi A; Iannicelli E
    Eur J Radiol; 2020 Mar; 124():108812. PubMed ID: 31951893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-Enhanced Ultrasonography Findings Correlate with Pathologic Grades of Pancreatic Neuroendocrine Tumors.
    Huang J; Chen J; Xu M; Zheng Y; Lin M; Huang G; Xie X; Xie X
    Ultrasound Med Biol; 2021 Aug; 47(8):2097-2106. PubMed ID: 33934943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of texture analysis for grading pancreatic neuroendocrine tumors on contrast-enhanced computed tomography and apparent diffusion coefficient maps.
    Ohki K; Igarashi T; Ashida H; Takenaga S; Shiraishi M; Nozawa Y; Ojiri H
    Jpn J Radiol; 2021 Jan; 39(1):66-75. PubMed ID: 32885378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
    Belousova E; Karmazanovsky G; Kriger A; Kalinin D; Mannelli L; Glotov A; Karelskaya N; Paklina O; Kaldarov A
    Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose whole organ CT perfusion of the pancreas: preliminary study.
    Li HO; Sun C; Xu ZD; Miao F; Zhang DJ; Chen JH; Li X; Wang XM; Liu C; Zhao B
    Abdom Imaging; 2014 Feb; 39(1):40-7. PubMed ID: 24258077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades.
    Salahshour F; Mehrabinejad MM; Zare Dehnavi A; Alibakhshi A; Dashti H; Ataee MA; Ayoobi Yazdi N
    Abdom Radiol (NY); 2020 Oct; 45(10):3155-3162. PubMed ID: 31897681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.